These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Chung MT, Lai HC, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Liu HS, Chu DW, Lin YW. Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296 [Abstract] [Full Text] [Related]
8. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW. Cancer; 2006 Aug 01; 107(3):579-90. PubMed ID: 16795071 [Abstract] [Full Text] [Related]
9. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. Zhang C, Li H, Zhou G, Zhang Q, Zhang T, Li J, Zhang J, Hou J, Liew CT, Yin D. J Pathol; 2007 Jun 01; 212(2):134-42. PubMed ID: 17471463 [Abstract] [Full Text] [Related]
10. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis. Dees C, Schlottmann I, Funke R, Distler A, Palumbo-Zerr K, Zerr P, Lin NY, Beyer C, Distler O, Schett G, Distler JH. Ann Rheum Dis; 2014 Jun 01; 73(6):1232-9. PubMed ID: 23698475 [Abstract] [Full Text] [Related]
11. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells. Qin X, Zhang H, Zhou X, Wang C, Zhang H, Zhang X, Ye L. Transl Res; 2007 Nov 01; 150(5):281-94. PubMed ID: 17964517 [Abstract] [Full Text] [Related]
12. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma. Ding SL, Yang ZW, Wang J, Zhang XL, Chen XM, Lu FM. World J Gastroenterol; 2015 May 28; 21(20):6317-28. PubMed ID: 26034368 [Abstract] [Full Text] [Related]
14. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma. Huang J, Zhang YL, Teng XM, Lin Y, Zheng DL, Yang PY, Han ZG. BMC Cancer; 2007 Jul 12; 7():126. PubMed ID: 17626620 [Abstract] [Full Text] [Related]
15. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. Regel I, Eichenmüller M, Mahajan UM, Hagl B, Benitz S, Häberle B, Vokuhl C, von Schweinitz D, Kappler R. J Cancer Res Clin Oncol; 2020 May 12; 146(5):1153-1167. PubMed ID: 32189106 [Abstract] [Full Text] [Related]
17. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, Martínez-Ansó E, Prieto J, Qian C. Cancer Res; 2009 Sep 01; 69(17):6951-9. PubMed ID: 19690140 [Abstract] [Full Text] [Related]
18. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis. Long XR, He Y, Huang C, Li J. Int J Oncol; 2014 Jun 01; 44(6):1915-22. PubMed ID: 24714841 [Abstract] [Full Text] [Related]
19. Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells. Liu J, Ding X, Tang J, Cao Y, Hu P, Zhou F, Shan X, Cai X, Chen Q, Ling N, Zhang B, Bi Y, Chen K, Ren H, Huang A, He TC, Tang N. PLoS One; 2011 Jun 01; 6(11):e27496. PubMed ID: 22110662 [Abstract] [Full Text] [Related]
20. Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma. Takagi H, Sasaki S, Suzuki H, Toyota M, Maruyama R, Nojima M, Yamamoto H, Omata M, Tokino T, Imai K, Shinomura Y. J Gastroenterol; 2008 Jun 01; 43(5):378-89. PubMed ID: 18592156 [Abstract] [Full Text] [Related] Page: [Next] [New Search]